Skip to main content

Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 11, 2025.

via HealthDay

THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according to a study published online July 7 in JAMA Internal Medicine.

Jeffry Florian, Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues examined the effects of four weeks of twice-daily CBD use on the liver and endocrine hormones using a dose within the range consumers are taking with unregulated CBD products in a trial involving 201 healthy adults. The participants were randomly assigned to receive CBD (5 mg/kg/day) or placebo for 28 days.

The researchers found that 5.6 and 0 percent of participants in the CBD and placebo groups, respectively, had elevation of liver enzyme (aspartate aminotransferase or alanine aminotransferase) levels greater than three times the upper limit of normal. Seven participants met the withdrawal criteria for potential drug-induced liver injury, which was detected at day 21 and day 28 in two and five participants, respectively. Between the CBD and placebo groups, no differences were seen in change from baseline for total testosterone and inhibin B in male participants or thyrotropin, total triiodothyronine, and free thyroxine in all participants.

"As CBD users may not notice these changes on their own, this study highlights the need for caution and potentially routine monitoring in CBD users," the authors write.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Follow-Up on Blood-Based Colorectal Cancer Screening Results Is Low

TUESDAY, Aug. 5, 2025 -- Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within...

Current Medical Use of Rx Stimulants for ADHD Up in Teens From 2005 to 2023

TUESDAY, Aug. 5, 2025 -- Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and...

Study Estimates Global Burden of Vertically Transmitted Hepatitis C

TUESDAY, Aug. 5, 2025 -- Each year, nearly 74,000 children are born with hepatitis C virus (HCV) around the world, according to a study published online July 23 in The Lancet...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.